By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

XLT Biopharmaceuticals Ltd. 

Kiryat Weizmann

Rehovot    76100  Israel
Phone: 08-940-5134 Fax: 08-940-5017


SEARCH JOBS


Industry
Biotechnology

Segment
Genomics





Company News
XLT Biopharmaceuticals Ltd. Signs $108M Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio Pharmaceuticals 3/20/2008 6:22:29 AM
XLT Biopharmaceuticals Ltd. Announces Delisting From the Official List of the United Kingdom Listing Authority Processing 10/31/2007 8:42:07 AM
XLT Biopharmaceuticals Ltd. AGM / EGM Postponed Until October 2, 2007 9/25/2007 12:32:01 PM
XLT Biopharmaceuticals Ltd. to Discuss the Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 9/11/2007 10:46:27 AM
XLT Biopharmaceuticals Ltd. Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 9/10/2007 8:32:56 AM
XLT Biopharmaceuticals Ltd. to Present at the Arch Investment Conference 9/5/2007 10:02:41 AM
XLT Biopharmaceuticals Ltd. Annual General Meeting 8/15/2007 11:29:01 AM
The Day In Review: Sanofi-Aventis (France) (SASY.PA) Loses Lovenox Patent 2/9/2007 5:04:04 PM
XLT Biopharmaceuticals Ltd. Notice Of AGM 9/26/2006 12:47:00 PM
XLT Biopharmaceuticals Ltd. Announces Financial Results For The Six Months Ended June 30, 2006 8/15/2006 10:16:30 AM
12
//-->